Description

Product information

IUPAC-name      1-(1,3-Benzodioxol-5-yl)-N-ethylpropan-2-amine

Synonyms  MDEA, MDE, Eve, 3,4-MDEA, 3,4-Methylenedioxy-N-ethylamphetamine, 3,4-Methylenedioxyethylamphetamine

Formal name  N-ethyl-α-methyl-1,3-benzodioxole-5-ethanamine, monohydrochloride

Cas number    82801-81-8, 74341-78-9 HCI

Formula   C₁₂H₁₇NO₂, C₁₂H₁₇NO₂ • HCl

Molar Mass   207.273 g·mol⁻¹

Purity                 98.0 % min.

Formulation    Powder, Solid, Crystals

MDEA, MDE, Eve, 3,4-MDEA, 3,4-Methylenedioxy-N-ethylamphetamine, 3,4-Methylenedioxyethylamphetamine

MDEA, also known as Eve, is a substance found in the amphetamine class. It’s produced by increasing the levels of certain chemicals in the brain. These include serotonin, dopamine, and norepinephrine. It can also cause hallucinations and other effects.

In 1976, Alexander Shulgin became the first known human user of MDEA. He noted that its effects were similar to those of MDMA, though it acted faster and had a shorter duration. In 1980, a comprehensive evaluation of the drug was published. In 1991, Shulgin wrote a book about his experiences with the substance.

In 1985, MDEA was made available as a legal substitute for the illegal substance MDMA in the US. However, since then, it has rarely been sold on its own. It’s also been used as an ingredient in the production of “Ecstasy,” a drug that’s commonly used for treating anxiety and depression.

Due to the lack of reliable information about the effects of MDEA, it’s not possible to determine its pharmacological properties or metabolism. Therefore, it’s important that users follow the proper precautions when using this substance.

More About MDEA

In 1985, the drug MDMA was legalized in the US. However, in August 1987, it was taken off the market and placed on the Schedule I substance list. Since then, it has mostly been used as an additive or a substitute for various drugs, such as ecstasy. According to studies conducted in the 1990s, around four percent of ecstasy tablets contain traces of MDEA.

Although it shares many of the same properties as MDMA, the active ingredient of MDEA is less potent and is considered to be less desirable. This makes it a less desirable alternative for people who are looking for an uplifting and pro-social experience during their party. Most commonly, this drug is produced and sold in the illicit market through small batches.

Chemistry

The MDEA is a synthetic version of the amphetamine class. It is composed of a phenethylamine core and an ethyl chain with a methyl substitution. The core of the drug is bound to an amino acid group through a phenyl ring.

MDEA is also characterized by an ethyl substitution on RN. This change brings about the formation of a methylenedioxy ring, which is similar to the entactogens found in MDMA and other drugs.

Pharmacology

MDEA is a drug that can be used to treat schizophrenia and other mental disorders by blocking the effects of certain neurotransmitters, such as serotonin, dopamine, and noradrenaline. These chemicals are responsible for regulating various aspects of pleasure and focus.

MDEA is known to cause a “stoning” effect when it is released over the dopamine. This is because the higher activity of the drug compared to MDMA leads to the release of more serotonin.

MDEA also stimulates the release of prolactin and oxytocin, which are hormones that are being studied for their possible roles in regulating the feeling of love and trust.

The toxicological and physiological properties of this compound has not been analyzed. Usage of this Chemical should be for research and forensic purposes only.

WARNING This product is not for human or veterinary use.

This product is only available to persons of 21 years old and above.

Hazard statement(s)